NCT01464424

Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)

Assessment of Late Day IOP Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 84 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to assess efficacy and tolerability of travoprost 0.004% vs. bimatoprost 0.01% during the after office hour period (4 pm to 8 pm) in subjects with open-angle glaucoma or ocular hypertension after 6 weeks of treatment.

Conditions

• Glaucoma
• Ocular Hypertension
• Open-Angle Glaucoma

Interventions

Type	Name	Description
DRUG	Travoprost 0.004% ophthalmic solution
DRUG	Bimatoprost 0.01% ophthalmic solution

Timeline

• Start date: 2011-10-01
• Primary completion: 2012-06-01
• Completion: 2012-06-01
• First posted: 2011-11-03
• Last updated: 2013-09-13
• Results posted: 2013-09-04